Humana (NYSE:HUM) Price Target Raised to $380.00 at Bank of America

Humana (NYSE:HUM) had its price target lifted by analysts at Bank of America from $340.00 to $380.00 in a research report issued to clients and investors on Wednesday,MarketScreener reports. Bank of America‘s price objective indicates a potential upside of 4.59% from the company’s current price.

Several other equities research analysts have also commented on the stock. William Blair started coverage on shares of Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating for the company. Mizuho boosted their target price on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. JPMorgan Chase & Co. upped their target price on Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a report on Monday, June 8th. Seaport Research Partners downgraded Humana to a “neutral” rating in a research report on Wednesday, May 20th. Finally, Zacks Research upgraded Humana from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $293.09.

Humana Price Performance

Shares of NYSE:HUM opened at $363.31 on Wednesday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock’s fifty day simple moving average is $292.50 and its two-hundred day simple moving average is $243.15. Humana has a 1-year low of $163.11 and a 1-year high of $380.86. The stock has a market cap of $43.62 billion, a PE ratio of 38.81, a price-to-earnings-growth ratio of 2.05 and a beta of 0.76.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts forecast that Humana will post 9.04 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Sound View Wealth Advisors Group LLC grew its stake in Humana by 3.5% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock worth $272,000 after buying an additional 36 shares during the period. CoreCap Advisors LLC raised its stake in shares of Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the period. Insigneo Advisory Services LLC lifted its holdings in shares of Humana by 3.0% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock valued at $386,000 after acquiring an additional 43 shares in the last quarter. Columbus Macro LLC lifted its holdings in shares of Humana by 5.5% during the 4th quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock valued at $210,000 after acquiring an additional 43 shares in the last quarter. Finally, Fiduciary Alliance LLC boosted its position in Humana by 0.9% during the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after purchasing an additional 49 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.